Clinical Trials List
Protocol Number178-CL-092
2010-11-01 - 2011-10-31
Phase I
Terminated1
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
0 participants
